Condition
GIST - Gastrointestinal Stromal Tumor clinical trials and research
As of November 12, 2026, Find a Trial lists 6 GIST - Gastrointestinal Stromal Tumor clinical trials that are recruiting, at sites in 3 countries (most in China (4), United States (2), South Korea (1)). By phase: Phase 2 (2), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 3Countries
Newest GIST - Gastrointestinal Stromal Tumor clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| GIST Patient Registry for real-world insights | — | Wayne, New Jersey | Recruiting | Jul 13, 2026 |
| Two-tooth endoscopic clip to help remove and close stomach GISTs | — | Beijing | Recruiting | May 12, 2026 |
| Regorafenib plus envafolimab versus physician's choice for metastatic GIST with KIT exon 17 mutation | Phase 2 | Beijing, Beijing Municipality | Recruiting | Apr 30, 2026 |
| KQB198 plus imatinib for first-line advanced or metastatic GIST | Phase 2 | Los Angeles, California and 16 other locations | Recruiting | Feb 12, 2026 |
| NB003 for Advanced GIST: testing a new therapy vs regorafenib in adults | Phase 2/3 | Hefei, Anhui and 31 other locations | Recruiting | Jan 30, 2026 |
| Evaluation of a new robotic surgical system for major gastrointestinal and urologic surgeries | — | Hong Kong | Recruiting | Apr 13, 2025 |
All recruiting trials (6)
-
GIST Patient Registry for real-world insights
This registry collects medical information from people with GIST to see how the disease behaves in real life and to help improve care.
-
Two-tooth endoscopic clip to help remove and close stomach GISTs
Doctors will try a new two-tooth endoscopic clip used with a clip-and-line traction method during ESD and EFTR to see if it makes removing and closing gastric GISTs (2–5 cm) faster and safer for adults.
-
Regorafenib plus envafolimab versus physician's choice for metastatic GIST with KIT exon 17 mutation
This study will test whether combining regorafenib with the immune drug envafolimab helps people with metastatic GIST who have KIT exon 17 mutations and have stopped responding to standard treatments.
-
KQB198 plus imatinib for first-line advanced or metastatic GIST
This Phase 2 test will see if adding the experimental drug KQB198 to imatinib helps people with advanced or metastatic GIST who are starting first-line treatment.
-
NB003 for Advanced GIST: testing a new therapy vs regorafenib in adults
This trial tests NB003 in adults with advanced GI stromal tumors who have progressed on or cannot tolerate imatinib and sunitinib, comparing NB003 to regorafenib in different lines of therapy.
-
Evaluation of a new robotic surgical system for major gastrointestinal and urologic surgeries
This study is testing a new robotic surgery system to see if it can safely and effectively help patients with major gastrointestinal and urologic conditions like colorectal and prostate cancer.
Related topics
Quick answers
How many GIST - Gastrointestinal Stromal Tumor clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (4 trials), United States (2 trials), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.